Skip to content

The use of del Nido cardioplegia for the myocardial protection in the surgical treatment of acute Standford type A aortic dissection: A prospective randomized trial

The use of del Nido cardioplegia for the myocardial protection in the surgical treatment of acute Standford type A aortic dissection: A prospective randomized trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018701
Enrollment
Unknown
Registered
2018-10-04
Start date
2018-10-04
Completion date
Unknown
Last updated
2018-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic dissection

Interventions

Group 1:del Nido cardioplegia
Group 2:St. Thomas cardioplegia

Sponsors

Xijing Hospital of The Fourth Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosis of acute type A aortic dissection or intramural hematoma requires aortic arch replacement; 2. No surgical contraindications, including severe liver, kidney, heart, lung insufficiency, or a history of coma; 3. Age 18-75 years; 4. Obtain informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; 2. Preoperative use of inotropic pharmacologic support; 3. Preoperative use of mechanical circulatory support; 4. Preoperative coronary malperfusion; 5. Patients with serious heart disease (such as congestive heart failure, untreated or worsened arrhythmias, ventricular arrhythmias); 6. Patients with myocardial infarction occurred within 3 months before enrollment; 7. Preoperative complications included severe cerebral and visceral malperfusion, leading to stroke, coma, renal failure, gastrointestinal bleeding; 8. Preoperative cardiac troponin I (cTnI) greater than 0.3 ng/ml; 9. unwilling to participate in this study.

Design outcomes

Primary

MeasureTime frame
Cardiac Troponin I (cTnI);

Secondary

MeasureTime frame
Vasoactive-inotropic Score (VIS);rate of return to spontaneous rhythm ;Debrillation;Changes of left ventricular ejection fraction after operation;CPB time;cross-clamp time;circulatory arrest time;total volume of cardioplegia;number of cardioplegia doses administered;blood transfusion volume;length of intensive care unit;mechanical ventilation time;Postoperative hospital stay;Postoperative complications;In-hospital mortality;30 day postoperative mortality;

Countries

China

Contacts

Public ContactDUAN WEIXUN

Xijing Hospital of The Fourth Military Medical University

duanweixun@126.com+86 13519182656

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026